3003 ORAL Cetuximab plus irinotecan in patients (pts) with metastatic colorectal cancer (mCRC) failing prior oxaliplatin-based therapy: the EPIC trial

✍ Scribed by W. Scheithauer; A. Sobrero; H.J. Lenz; J. Maurel; M. Lutz; G. Middleton; M. Saleh; A. Zubel; K. Williams; H.A. Burris III

• Book ID: 118625773
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 80 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(07)70931-x